World HUPO 2026: Asia-Pacific Ambition and the Road to Predictive Biology
Conversations at HUPO 2026 revolved around questions that reach beyond the proteomics community: who will develop disease, why treatment fails, and whether a computational model can help us decide which experiment to run next. The post World HUPO 2026: Asia-Pacific Ambition and the Road to Predictive Biology appeared first on GEN - Genetic Engineering and Biotechnology News .
In the opening keynote of the Singapore Human Proteome Organization (HUPO) congress, China's National Center for Protein Sciences chairman, Fuchu He, presented an ambitious roadmap for the Proteomic Navigator of the Human Body, or π-HuB. The plan envisions a multi-billion renminbi investment over three decades to profile organs, tissues, cell types, and individuals, ultimately aiming to predict the proteomic states of each person across their lifetime.
This goal, while challenging, holds promise for personalized medicine and understanding the complex interplay between biology, environment, and lifestyle in disease development.
Written by urgent.news from GEN Biotechnology's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
